West Pharmaceutical Services (WST) Total Liabilities (2009 - 2026)

West Pharmaceutical Services has disclosed Total Liabilities across 18 years of filings, most recently posting $1.1 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 6.11% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (up 6.11% YoY), while the FY2025 annual figure was $1.1 billion, up 13.83% from the prior year.
• Total Liabilities came in at $1.1 billion for Q2 2026 at West Pharmaceutical Services, down from $1.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.1 billion in Q1 2026 to a low of $846.0 million in Q3 2022.
• Average Total Liabilities over 5 years is $967.8 million, with a median of $942.4 million recorded in 2022.
• Year-over-year, Total Liabilities declined 10.03% in 2022 and rose 19.71% in 2026.
• Over 5 years, Total Liabilities stood at $931.9 million in 2022, then climbed by 1.78% to $948.5 million in 2023, then gained by 1.33% to $961.1 million in 2024, then increased by 13.83% to $1.1 billion in 2025, then dropped by 0.71% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.